| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Traws Pharma, Inc. (TRAW) has 11 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. TRAW is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.79M | $3.05M | +3.59M | |
| COO | 150.6K | $256.0K | - | |
| CEO | 147.8K | $251.2K | - | |
| Other | 116.0K | $197.2K | - | |
| Other | 113.9K | $193.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2021 | Shoemaker Mary Teresa | Director | Buy | 13,000 | $1.00 | $13,000.00 | +34.5% | |
| Feb 16, 2021 | Oler Abraham N. | SVP Corp Dev &Gen Counsel | Buy | 12,000 | $1.00 | $12,000.00 | +8.6% | |
| Feb 16, 2021 | Guerin Mark Patrick | Chief Financial Officer | Buy | 15,000 | $1.00 | $15,000.00 | +11.5% | |
| Feb 16, 2021 | Fruchtman Steven M | President, Chief Executive Off | Buy | 20,000 | $1.00 | $20,000.00 | +9.2% | |
| Feb 16, 2021 | Marino James J | Director | Buy | 25,000 | $1.00 | $25,000.00 | +12.2% | |
| Dec 11, 2020 | Oler Abraham N. | SVP Corp Dev &Gen Counsel | Buy | 30,000 | $0.32 | $9,600.00 | +27.3% | |
| Nov 27, 2020 | Guerin Mark Patrick | Chief Financial Officer | Buy | 21,369 | $0.26 | $5,555.94 | +9.1% | |
| Nov 25, 2020 | Shoemaker Mary Teresa | Director | Buy | 37,735 | $0.27 | $9,999.78 | New | |
| Nov 25, 2020 | Oler Abraham N. | SVP Corp Dev &Gen Counsel | Buy | 20,000 | $0.26 | $5,120.00 | +22.2% | |
| Nov 25, 2020 | Fruchtman Steven M | President, Chief Executive Off | Buy | 40,000 | $0.26 | $10,360.00 | +22.7% |